Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 2Other hematologic neoplasm 1Myeloid 1Lymphoid 1CNS 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 240Lymphoma 232Lymphoma, Non-Hodgkin 205Leukemia, Lymphocytic, Chronic, B-Cell 184Lymphoma, Large B-Cell, Diffuse 177Lymphoma, Follicular 172Lymphoma, B-Cell 112Lymphoma, Mantle-Cell 106Hodgkin Disease 105Leukemia, Myeloid, Acute 101Recurrence 98Multiple Myeloma 92Burkitt Lymphoma 90Leukemia 78Neoplasms 68Lymphoma, B-Cell, Marginal Zone 59Hematologic Neoplasms 59Myelodysplastic Syndromes 56Waldenstrom Macroglobulinemia 47Lymphoma, T-Cell 43Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 41Lymphoma, T-Cell, Peripheral 36Lymphoma, T-Cell, Cutaneous 31Leukemia, Biphenotypic, Acute 30Leukemia, Myelogenous, Chronic, BCR-ABL Positive 29Leukemia, B-Cell 27Mycosis Fungoides 25Lymphoma, Large-Cell, Anaplastic 25Sarcoma 24Breast Neoplasms 22

Interventions

thymoglobulin 1fludarabine 1Rituximab 1Melphalan 1Levetiracetam 1Cyclophosphamide 1Busulfan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
beta-Thalassemia × Lymphoid × 90 days × Clear all
NCT05735717 2026-04-06

MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies

Masonic Cancer Center, University of Minnesota

Phase 2 Recruiting
70 enrolled
CNSClassical hematologyLymphoidOther hematologic neoplasm

Chromosome 7, monosomy, Anemia, Refractory, with Excess of Blasts, Chromosome Aberrations, Influenza, Human, Neurofibromatosis 1, Leukemia, Myeloid, Acute, beta-Thalassemia, Neoplasm, Residual, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myelomonocytic, Juvenile

Data powered by HemOnc (CC BY 4.0) Colophon âš¡